Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Koller

Showing results (101-110 of 415) with videos related to

Pageof 42
Sort By:
Drugs & Aging|October 24, 2000
Early Parkinson's disease: what is the best approach to treatmentA H Hristova, W C Koller
Neurology|October 1, 1990
Selegiline HC1: Selective MAO-type B inhibitorW C Koller, L T Giron
Neurology|October 13, 2004
A novel formulation of selegiline for the treatment of Parkinson's diseaseJames W Tetrud, William C Koller
Neurology|July 1, 1997
Issues in the early diagnosis of Parkinson's diseaseW C Koller, E B Montgomery
Journal of Neurology|June 9, 1998
Quality of life and Parkinson's disease: the CR FIRST StudyP G Wasielewski, W C Koller
Neurology|June 20, 1998
Mechanism of action of dopaminergic agents in Parkinson's diseaseW C Koller, M G Rueda
Neurology|January 1, 1986
Efficacy of primidone in essential tremorW C Koller, V L Royse
The British Journal of Radiology|October 29, 2010
Cytological analysis of the response of malignant tumors to irradiation as an approach to a biological basis for dosage in radiotherapyP C KOLLER, D W SMITHERS
Geriatrics|May 1, 1989
Tremor disorders of aging: diagnosis and managementW C Koller, S J Huber
Neurology|July 1, 1987
Essential tremor: a reviewL J Findley, W C Koller
Pageof 42

Showing results (101-110 of 415) with videos related to

Sort By:
Pageof 42
Drugs & Aging|October 24, 2000
Early Parkinson's disease: what is the best approach to treatmentA H Hristova, W C Koller
Neurology|October 1, 1990
Selegiline HC1: Selective MAO-type B inhibitorW C Koller, L T Giron
Neurology|October 13, 2004
A novel formulation of selegiline for the treatment of Parkinson's diseaseJames W Tetrud, William C Koller
Neurology|July 1, 1997
Issues in the early diagnosis of Parkinson's diseaseW C Koller, E B Montgomery
Journal of Neurology|June 9, 1998
Quality of life and Parkinson's disease: the CR FIRST StudyP G Wasielewski, W C Koller
Neurology|June 20, 1998
Mechanism of action of dopaminergic agents in Parkinson's diseaseW C Koller, M G Rueda
Neurology|January 1, 1986
Efficacy of primidone in essential tremorW C Koller, V L Royse
The British Journal of Radiology|October 29, 2010
Cytological analysis of the response of malignant tumors to irradiation as an approach to a biological basis for dosage in radiotherapyP C KOLLER, D W SMITHERS
Geriatrics|May 1, 1989
Tremor disorders of aging: diagnosis and managementW C Koller, S J Huber
Neurology|July 1, 1987
Essential tremor: a reviewL J Findley, W C Koller
Pageof 42